TECHBio-Techne Corp
Company Overview
Name
52W High
52W Low
Market Cap
Dividend Yield
Price/earnings
P/E
Tags
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
EV to Revenue
Price to Book value
Price to Earnings
Additional Data
Selling, General & Admin Expense
Research & Development Expense
Total Operating Expenses
Total Other Income / (Expense), net
Total Pre-Tax Income
Income Tax Expense
Earnings History
Estimated EPS
Reported EPS
N/ACompany Overview
Name
52W High
52W Low
Market Cap
Dividend Yield
Price/earnings
P/E
Tags
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
Net Income
EV to EBITDA
EV to Revenue
Price to Book value
Price to Earnings
Additional Data
Selling, General & Admin Expense
Research & Development Expense
Total Operating Expenses
Total Other Income / (Expense), net
Total Pre-Tax Income
Income Tax Expense
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
Company Info
CEO
Charles R. Kummeth
Location
Minnesota, USA
Exchange
Nasdaq
Website
https://bio-techne.com
Summary
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services.
Company Info
CEO
Charles R. Kummeth
Location
Minnesota, USA
Exchange
Nasdaq
Website
https://bio-techne.com
Summary
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services.
Community Research
Research from investors like you
Be the first to share your analysis on TECH
Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.
Symbol's posts
Rotation Season Is Here. Are You Still Heavy in Tech
Rotation Season Is Here. Are You Still Heavy in Tech
Money’s starting to move out of big tech and into other corners of the market as Wall Street cools off on the AI hype trade. After monster runs in names like , , and , a lot of traders are locking in gains and hunting for better risk reward elsewhere. The rotation seems to be leaning toward stuff like , , and industrial names that actually benefit if growth slows but the economy doesn’t fall apart. It’s not that AI is dead, it’s more that expectations got stretched and valuations got crowded fast. Feels like the market’s asking a real question now. Do you stick with mega cap tech and ride the volatility, or rotate into cheaper sectors before leadership really shifts? What’s your move right now, staying heavy in or spreading bets elsewhere.
Global Equities Back in Favor as Rate Cut Hopes Build
Global Equities Back in Favor as Rate Cut Hopes Build
Global equity funds just pulled in big money again, seeing their largest inflows in about five weeks as traders get more comfortable with the macro backdrop. Roughly $36 billion flowed into stock funds worldwide, showing investors are leaning back into equities after a run of AI-driven volatility. The shift looks tied to two big themes: cooling worries and renewed bets that cuts are still coming if inflation keeps losing steam. When both of those lines up, risk assets tend to benefit because cheap capital usually lifts stocks. Money wasn’t just piling into one region either. Europe and .S. equity funds both saw solid inflows, and Asian funds got a piece of the pie too. Sectors like , INDUSTRIALS, and METALS & MINING were among the biggest beneficiaries as portfolio managers repositioned into broader exposure. On the fixed income side, bond and money market funds are still getting action, while gold and precious metals saw some trimming as money rotated back into stocks. Overall, this flow picture tells you that traders aren’t throwing in the towel. Instead, they’re buying dips and leaning into the idea that easier policy and softer inflation data will keep markets supported. This isn’t a screaming breakout yet, but it’s a solid sign that confidence is slowly rebuilding in global equities across regions and sectors as the macro story evolves.
Ali Partovi’s Neo Takes Aim at Traditional Accelerators
Ali Partovi’s Neo Takes Aim at Traditional Accelerators
Ali Partovi’s Neo is trying to flip the accelerator game on its head. Instead of the usual heavy dilution, Neo is backing early founders with low-equity, founder-friendly terms that let them keep more upside if things work out. The big idea is simple: give capital and mentorship without taxing ownership early. That’s a sharp contrast to the traditional accelerator model that locks in fixed equity before a startup even finds product-market fit. If this catches on, it could shift how early-stage funding works across and $STARTUPS, especially as founders get more selective about who they partner with. Not a threat to the big names yet, but definitely pressure on the old playbook. More leverage for founders, less dilution upfront, and more competition in the space.
AI Reality Check Hits Wall Street
AI Reality Check Hits Wall Street
Wall Street is finally talking about the dark side of AI. After a huge run, a lot of and $software stocks are getting smacked as traders start worrying about disruption instead of just hype. Earnings misses, stretched valuations, and fears that AI could eat into existing businesses are all hitting sentiment. This selloff isn’t random. When a trade gets crowded like AI did, the market stops chasing stories and starts asking one thing. Where are the real profits? That’s why former leaders are getting chopped and volatility is creeping back in. Feels more like a reset than a full breakdown. AI isn’t dead, but the easy money phase is over. Now it’s about who can actually turn AI into cash flow instead of buzzwords. Big question now is whether this is just a breather or the start of a deeper tech shakeout. Markets about to decide.
No more topics to show


